BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19108567)

  • 1. Hyperphosphatemia in renal failure.
    Robb M
    RN; 2008 Dec; 71(12):26-30; quiz 31. PubMed ID: 19108567
    [No Abstract]   [Full Text] [Related]  

  • 2. When is Vitamin D contraindicated in dialysis patients?
    Lewin E; Olgaard K
    Semin Dial; 2009; 22(3):240-2. PubMed ID: 19572998
    [No Abstract]   [Full Text] [Related]  

  • 3. When is Vitamin D contraindicated in dialysis patients?
    Brown HJ; Cunningham J
    Semin Dial; 2009; 22(3):237-40. PubMed ID: 19572997
    [No Abstract]   [Full Text] [Related]  

  • 4. Salivary glands: a new player in phosphorus metabolism.
    Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
    J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.
    Gutiérrez OM; Wolf M
    Semin Dial; 2010; 23(4):401-6. PubMed ID: 20557490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate control: who, how and when? A comment.
    Sutton D
    J Ren Care; 2009 Mar; 35 Suppl 1():84-5. PubMed ID: 19222737
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hyperphosphataemia: practices and perspectives amongst the renal care community.
    Nagel CJ; Casal MC; Lindley E; Rogers S; Pancířová J; Kernc J; Copley JB; Fouque D
    J Ren Care; 2014 Dec; 40(4):230-8. PubMed ID: 24814866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of life.
    Gardulf A; Pålsson M; Nicolay U;
    Clin Nephrol; 2011 Apr; 75(4):319-27. PubMed ID: 21426886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using concordance with dosing techniques to achieve phosphate control.
    Koester LA; Rothstein M
    Nephrol News Issues; 2013 Nov; 27(12):22, 24, 26-8 passim. PubMed ID: 24354233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of uremic hyperphosphatemia.
    Schaefer K
    Clin Nephrol; 1996 Oct; 46(4):279-80. PubMed ID: 8905221
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
    Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
    J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
    Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
    J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
    Sullivan C; Sayre SS; Leon JB; Machekano R; Love TE; Porter D; Marbury M; Sehgal AR
    JAMA; 2009 Feb; 301(6):629-35. PubMed ID: 19211470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health approach to addressing hyperphosphatemia among dialysis patients.
    Sehgal AR; Sullivan C; Leon JB; Bialostosky K
    J Ren Nutr; 2008 May; 18(3):256-61. PubMed ID: 18410881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorus additives in food and their effect in dialysis patients.
    Uribarri J
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1290-2. PubMed ID: 19608709
    [No Abstract]   [Full Text] [Related]  

  • 16. Hidden phosphorus in popular beverages.
    Murphy-Gutekunst L
    Nephrol Nurs J; 2005; 32(4):443-5. PubMed ID: 16180787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the associations between modifying factors, individual health beliefs, and hemodialysis patients' adherence to a low-phosphorus diet.
    Elliott JO; Ortman C; Almaani S; Lee YH; Jordan K
    J Ren Nutr; 2015 Mar; 25(2):111-20. PubMed ID: 25282006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How KDIGO will (or will not) influence the management of hyperphosphatemia.
    Kovesdy CP
    Semin Dial; 2011; 24(1):35-6. PubMed ID: 21338391
    [No Abstract]   [Full Text] [Related]  

  • 19. Are calcium-based phosphate binders ever preferable in dialysis patients?
    Jain N; Reilly RF
    Semin Dial; 2014; 27(3):269-72. PubMed ID: 24620781
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphate is a uremic toxin.
    Burke SK
    J Ren Nutr; 2008 Jan; 18(1):27-32. PubMed ID: 18089440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.